pharmaceuticals
A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The BCG (Bacille Calmette-Guérin) vaccine, created in 1921, remains the sole TB vaccine. While it is 40% to 80% effective in young children, its efficacy is very low in adolescents and adults, leading to a worldwide push to create a more powerful vaccine. One effort is underway at the University of Montana Center for Translational Medicine. The center specializes in improving and creating vaccines by adding wh...
Kaiser Health News
On a narrow street lined with row houses and an auto body shop in the Kensington neighborhood of North Philadelphia, Marsella Elie climbs a home’s front steps and knocks hard on the door. A middle-aged man appears with a wary look on his face. “Hello, sir, how are you doing today?” asked Elie, wearing a royal-blue jacket embroidered with the city government’s Liberty Bell logo. “My name is Marsella. I’m working with the city. You heard about the overdoses that are going around in the neighborhood, right?” The man gives a cautious nod. Elie gestures to the pamphlets she’s holding about drug ove...
Kaiser Health News
When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database. One member of the FDA advisory committee was linked to hundreds of payments from Abbott totaling almost $200,000, according to a database maintained by the Department of Health and Human Services. Another was connected to 100 payments totaling about $100,000 and conducted research supported by about $50,000 from Abbott. A thi...
Kaiser Health News
When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database. One member of the FDA advisory committee was linked to hundreds of payments from Abbott totaling almost $200,000, according to a database maintained by the Department of Health and Human Services. Another was connected to 100 payments totaling about $100,000 and conducted research supported by about $50,000 from Abbott. A thi...
California Healthline
Insulin for Medicare beneficiaries “was costing 400 bucks a month on average. It now costs $35 a month.” President Joe Biden, in a March 22 speech The cost of insulin in the United States has risen considerably in recent years, with some estimates finding that Americans have paid around 10 times as much for the drug as people in other developed countries. But recent changes by the federal government and drug manufacturers have started to drive insulin prices down, something President Joe Biden often mentions at campaign events. Biden told the crowd at a March 19 campaign reception in Reno, Nev...
Kaiser Health News
Insulin for Medicare beneficiaries “was costing 400 bucks a month on average. It now costs $35 a month.” President Joe Biden, in a March 22 speech The cost of insulin in the United States has risen considerably in recent years, with some estimates finding that Americans have paid around 10 times as much for the drug as people in other developed countries. But recent changes by the federal government and drug manufacturers have started to drive insulin prices down, something President Joe Biden often mentions at campaign events. Biden told the crowd at a March 19 campaign reception in Reno, Nev...
California Healthline
Lawyers from the conservative Christian group that won the case to overturn Roe v. Wade are returning to the U.S. Supreme Court on Tuesday in pursuit of an urgent priority: shutting down access to abortion pills for women across the country. The case challenges the FDA’s regulation of mifepristone, a prescription-only drug approved in 2000 with a stellar safety record that is used in 63% of all U.S. abortions. Viewed across decades of anti-abortion activism, the case brought by the Alliance Defending Freedom represents a “moonshot” couched in technical arguments about pharmaceutical oversight ...
Kaiser Health News
Lawyers from the conservative Christian group that won the case to overturn Roe v. Wade are returning to the U.S. Supreme Court on Tuesday in pursuit of an urgent priority: shutting down access to abortion pills for women across the country. The case challenges the FDA’s regulation of mifepristone, a prescription-only drug approved in 2000 with a stellar safety record that is used in 63% of all U.S. abortions. Viewed across decades of anti-abortion activism, the case brought by the Alliance Defending Freedom represents a “moonshot” couched in technical arguments about pharmaceutical oversight ...
California Healthline
OCALA, Fla. — Fire Capt. Jesse Blaire steered his SUV through the mobile home park until he spotted the little beige house with white trim and radioed to let dispatchers know he’d arrived. There, Shawnice Slaughter waited on the steps, wiping sleep from her eyes. “Good morning, Shawnice,” Blaire said. “How are you feeling today?” “I’ve been good, I’ve been good,” Slaughter said. “Much better.” Three days earlier, Blaire — a paramedic who leads the fire department’s emergency medical team — met Slaughter at a nearby hospital. She had overdosed on opioids. It took four vials of an overdose rever...
Kaiser Health News
Céline Gounder, KFF Health News’ editor-at-large for public health, explained on “CBS Mornings” why many at-risk Americans do not know about medication to prevent HIV infection through sexual contact or do not have access to it. Only one-third of people who could benefit from the medication, known as preexposure prophylaxis or PrEP, are prescribed it, according to the Centers for Disease Control and Prevention.
Kaiser Health News
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら